NCT02377999View on ClinicalTrials.gov

Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts

PHASE2CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions

Anogenital Warts

Interventions

DRUG

Picato

Trial Locations (1)

2400

Bispebjerg Hospital, Copenhagen NV

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LEO Pharma

INDUSTRY